Michael Stimpel

1.2k total citations
28 papers, 947 citations indexed

About

Michael Stimpel is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Michael Stimpel has authored 28 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Pharmacology. Recurrent topics in Michael Stimpel's work include Blood Pressure and Hypertension Studies (13 papers), Heart Failure Treatment and Management (6 papers) and Menopause: Health Impacts and Treatments (6 papers). Michael Stimpel is often cited by papers focused on Blood Pressure and Hypertension Studies (13 papers), Heart Failure Treatment and Management (6 papers) and Menopause: Health Impacts and Treatments (6 papers). Michael Stimpel collaborates with scholars based in Germany, United States and France. Michael Stimpel's co-authors include Ludwig Neyses, H. Vetter, Stefan Kahlert, Gérard M. London, Alain P. Guérin, Sylvain J. Marchais, Bruno Pannier, Theo Pelzer, Michael Schümann and Manfred Neumann and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Hypertension.

In The Last Decade

Michael Stimpel

27 papers receiving 912 citations

Peers

Michael Stimpel
Naomichi Matsukawa Japan
Nozomu Inamoto Japan
Richard Reneland Sweden
Liliya M. Yamaleyeva United States
Tetsuro Yoshida Japan
Tadashi Konoshita Japan
Mariko Kajikawa Japan
Duncan J. Campbell Australia
Erin A. Booth United States
Londa Hathaway United States
Naomichi Matsukawa Japan
Michael Stimpel
Citations per year, relative to Michael Stimpel Michael Stimpel (= 1×) peers Naomichi Matsukawa

Countries citing papers authored by Michael Stimpel

Since Specialization
Citations

This map shows the geographic impact of Michael Stimpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stimpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stimpel more than expected).

Fields of papers citing papers by Michael Stimpel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stimpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stimpel. The network helps show where Michael Stimpel may publish in the future.

Co-authorship network of co-authors of Michael Stimpel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stimpel. A scholar is included among the top collaborators of Michael Stimpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stimpel. Michael Stimpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stimpel, Michael. (2018). Leben mit Herzerkrankungen.
2.
Pelzer, Theo, et al.. (2002). Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition. Journal of Hypertension. 20(5). 1001–1006. 19 indexed citations
3.
Pelzer, Theo, Michael Schümann, Manfred Neumann, et al.. (2000). 17β-Estradiol Prevents Programmed Cell Death in Cardiac Myocytes. Biochemical and Biophysical Research Communications. 268(1). 192–200. 89 indexed citations
4.
Blacher, Jacques, et al.. (2000). Long-Term Cardiovascular Effects of High “Osteoprotective” Dose Levels of 17β-Estradiol in Spontaneously Hypertensive Rats. Cardiovascular Drugs and Therapy. 14(3). 303–307. 14 indexed citations
5.
Eickels, Martin van, et al.. (1999). Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. Naunyn-Schmiedeberg s Archives of Pharmacology. 359(5). 394–399. 34 indexed citations
6.
Chrysant, Steven G. & Michael Stimpel. (1998). Antihypertensive Effectiveness of a Very Low Fixed-Dose Combination of Moexipril and Hydrochlorothiazide. Journal of Cardiovascular Pharmacology. 31(3). 384–390. 7 indexed citations
7.
8.
Kahlert, Stefan, et al.. (1998). Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. Journal of Hypertension. 16(3). 377–384. 24 indexed citations
9.
10.
White, William B., et al.. (1997). USEFULNESS OF MOEXIPRIL AND HYDROCHLOROTHIAZIDE IN MODERATELY SEVERE ESSENTIAL HYPERTENSION. American Journal of Therapeutics. 4(4). 123–129. 8 indexed citations
11.
Ma, Yanfei, et al.. (1997). Aging- and ovariectomy-related skeletal changes in spontaneously hypertensive rats. The Anatomical Record. 249(2). 173–180. 15 indexed citations
12.
Kahlert, Stefan, et al.. (1997). Cardiac myocytes and fibroblasts contain functional estrogen receptors1. FEBS Letters. 416(1). 107–112. 317 indexed citations
13.
Stimpel, Michael, et al.. (1996). Moexipril as Add-On Therapy to Hydrochlorothiazide in Moderate to Severe Hypertension. Cardiology. 87(4). 313–318. 4 indexed citations
14.
Stimpel, Michael, et al.. (1996). Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension. Journal of Cardiovascular Pharmacology. 28(6). 769–773. 9 indexed citations
15.
Chrysant, Steven G. & Michael Stimpel. (1996). A Comparison of the Antihypertensive Effectiveness of a Combination of Moexipril or Sustained‐Release Verapamil with Low‐Dose Hydrochlorothiazide. The Journal of Clinical Pharmacology. 36(8). 701–706. 3 indexed citations
16.
King, Nicholas M. P., et al.. (1995). Moexipril in the Treatment of Mild to Moderate Essential Hypertension: Comparison with Sustained‐Release Verapamil. The Journal of Clinical Pharmacology. 35(8). 794–799. 11 indexed citations
17.
White, William B., et al.. (1995). Tricenter Assessment of the Efficacy of the ACE Inhibitor, Moexipril, by Ambulatory Blood Pressure Monitoring. The Journal of Clinical Pharmacology. 35(3). 233–238. 9 indexed citations
18.
Stimpel, Michael, Yanfei Ma, Noriaki Yamamoto, & Yongyong Chen. (1995). Impact of antihypertensive therapy on postmenopausal osteoporosis. Journal of Hypertension. 13(12). 1852???1856–1852???1856. 29 indexed citations
19.
Safar, Michel E., Michael Stimpel, & Alberto Zanchetti. (1994). Hypertension in Postmenopausal Women. 9 indexed citations
20.
Dickstein, Kenneth, et al.. (1994). Comparison of the Efficacy of Three Dose Levels of Moexipril Versus Placebo as Add-On Therapy to Hydrochlorothiazide in Patients with Moderate Hypertension. Journal of Cardiovascular Pharmacology. 24(2). 247–255. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naomichi Matsukawa Breakdown of academic impact, for papers by Nozomu Inamoto Breakdown of academic impact, for papers by Richard Reneland Breakdown of academic impact, for papers by Liliya M. Yamaleyeva Breakdown of academic impact, for papers by Tetsuro Yoshida Breakdown of academic impact, for papers by Tadashi Konoshita Breakdown of academic impact, for papers by Mariko Kajikawa Breakdown of academic impact, for papers by Duncan J. Campbell Breakdown of academic impact, for papers by Erin A. Booth Breakdown of academic impact, for papers by Londa Hathaway
Rankless by CCL
2026